Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184–5.
Article
CAS
PubMed
Google Scholar
Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010;362(4):329–44.
Article
CAS
PubMed
Google Scholar
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–6.
Article
CAS
PubMed
Google Scholar
Jan A, Adolfsson O, Allaman I, Buccarello AL, Magistretti PJ, Pfeifer A, et al. Aβ42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Aβ42 species. J Biol Chem. 2011;286(10):8585–96.
Article
CAS
PubMed
Google Scholar
Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101–12.
Article
CAS
PubMed
Google Scholar
Kittelberger KA, Piazza F, Tesco G, Reijmers LG. Natural amyloid-β oligomers acutely impair the formation of a contextual fear memory in mice. PLoS One. 2012;7(1), e29940.
Article
CAS
PubMed
PubMed Central
Google Scholar
Poling A, Morgan-Paisley K, Panos JJ, Kim EM, O’Hare E, Cleary JP, et al. Oligomers of the amyloid-β protein disrupt working memory: confirmation with two behavioral procedures. Behav Brain Res. 2008;193(2):230–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat Neurosci. 2005;8(1):79–84.
Article
CAS
PubMed
Google Scholar
Ferreira ST, Vieira MN, De Felice FG. Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases. IUBMB Life. 2007;59(4-5):332–45.
Article
CAS
PubMed
Google Scholar
Benilova I, Karran E, De Strooper B. The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes. Nat Neurosci. 2012;15(3):349–57.
Article
CAS
PubMed
Google Scholar
Kummer MP, Heneka MT. Truncated and modified amyloid-β species. Alzheimers Res Ther. 2014;6(3):28.
Article
PubMed
PubMed Central
Google Scholar
Choi YJ, Chae S, Kim JH, Barald KF, Park JY, Lee SH. Neurotoxic amyloid β oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow. Sci Rep. 2013;3:1921.
Article
PubMed
PubMed Central
Google Scholar
Cedazo-Minguez A, Winblad B. Biomarkers for Alzheimer’s disease and other forms of dementia: clinical needs, limitations and future aspects. Exp Gerontol. 2010;45(1):5–14.
Article
CAS
PubMed
Google Scholar
Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6(3):131–44.
Article
CAS
PubMed
Google Scholar
Yang L, Rieves D, Ganley C. Brain amyloid imaging—FDA approval of florbetapir F18 injection. N Engl J Med. 2012;367(10):885–7.
Article
CAS
PubMed
Google Scholar
Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. Neuroimaging markers for the prediction and early diagnosis of Alzheimer’s disease dementia. Trends Neurosci. 2011;34(8):430–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nordberg A, Rinne JO, Kadir A, Langstrom B. The use of PET in Alzheimer disease. Nat Rev Neurol. 2010;6(2):78–87.
Article
CAS
PubMed
Google Scholar
Wang C, Cui Y, Yang J, Zhang J, Yuan D, Wei Y, et al. Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer’s disease in patients with the apolipoprotein E4 genotype. Biomarkers. 2015;20(1):84–8.
Article
CAS
PubMed
Google Scholar
Ma L, Chen J, Wang R, Han Y, Zhang J, Dong W, et al. The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairment. J Clin Neurosci. 2015;22(4):649–52.
Article
CAS
PubMed
Google Scholar
Ma L, Wang R, Han Y, Sheng S, Zhu J, Ji Z, et al. Development of a novel urine Alzheimer-associated neuronal thread protein ELISA kit and its potential use in the diagnosis of Alzheimer’s disease. J Clin Lab Anal. 2015;30(4):308–14.
Article
PubMed
Google Scholar
Bermejo-Pareja F, Antequera D, Vargas T, Molina JA, Carro E. Saliva levels of Abeta1-42 as potential biomarker of Alzheimer’s disease: a pilot study. BMC Neurol. 2010;10:108.
Article
PubMed
PubMed Central
Google Scholar
Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20(4):415–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ait-ghezala G, Abdullah L, Volmar CH, Paris D, Luis CA, Quadros A, et al. Diagnostic utility of APOE, soluble CD40, CD40L, and Aβ1–40 levels in plasma in Alzheimer’s disease. Cytokine. 2008;44(2):283–7.
Article
CAS
PubMed
Google Scholar
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol. 2012;69(10):1318–25.
Article
PubMed
Google Scholar
Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, et al. Classification and prediction of clinical Alzheimer’s diagnosis based on plasma signaling proteins. Nat Med. 2007;13(11):1359–62.
Article
CAS
PubMed
Google Scholar
Xia W, Yang T, Shankar G, Smith IM, Shen Y, Walsh DM, Selkoe DJ. A specific enzyme-linked immunosorbent assay for measuring β-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch Neurol. 2009;66(2):190–9.
Article
PubMed
PubMed Central
Google Scholar
Bjorkqvist M, Ohlsson M, Minthon L, Hansson O. Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer’s disease. PLoS One. 2012;7(1), e29868.
Article
PubMed
PubMed Central
Google Scholar
Yang T, Hong S, O’Malley T, Sperling RA, Walsh DM, Selkoe DJ. New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF. Alzheimers Dement. 2013;9(2):99–112.
Article
PubMed
PubMed Central
Google Scholar
Hyman BT, Smith C, Buldyrev I, Whelan C, Brown H, Tang MX, Mayeux R. Autoantibodies to amyloid-β and Alzheimer’s disease. Ann Neurol. 2001;49(6):808–10.
Article
CAS
PubMed
Google Scholar
Irizarry MC. Biomarkers of Alzheimer disease in plasma. NeuroRx. 2004;1(2):226–34.
Article
PubMed
PubMed Central
Google Scholar
Thambisetty M, Lovestone S. Blood-based biomarkers of Alzheimer’s disease: challenging but feasible. Biomark Med. 2010;4(1):65–79.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H, et al. Biological markers of amyloid β-related mechanisms in Alzheimer’s disease. Exp Neurol. 2010;223(2):334–46.
Article
CAS
PubMed
Google Scholar
An SSA, Lim KT, Oh HJ, Lee BS, Zukic E, Ju YR, et al. Differentiating blood samples from scrapie infected and non-infected hamsters by detecting disease-associated prion proteins using multimer detection system. Biochem Biophys Res Commun. 2010;392(4):505–9.
Article
CAS
PubMed
Google Scholar
Biancalana M, Koide S. Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta. 2010;1804(7):1405–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang YJ, Zhou HD, Zhou XF. Clearance of amyloid-β in Alzheimer’s disease: progress, problems and perspectives. Drug Discov Today. 2006;11(19-20):931–8.
Article
CAS
PubMed
Google Scholar
Sehlin D, Söllvander S, Paulie S, Brundin R, Ingelsson M, Lannfelt L, et al. Interference from heterophilic antibodies in amyloid-β oligomer ELISAs. J Alzheimers Dis. 2010;21(4):1295–301.
Article
CAS
PubMed
Google Scholar
Kuo YM, Emmerling MR, Lampert HC, Hempelman SR, Kokjohn TA, Woods AS, et al. High levels of circulating Aβ42 are sequestered by plasma proteins in Alzheimer’s disease. Biochem Biophys Res Commun. 1999;257(3):787–91.
Article
CAS
PubMed
Google Scholar
Kuo YM, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, et al. Amyloid-β peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun. 2000;268(3):750–6.
Article
CAS
PubMed
Google Scholar
Lim K, Kim SY, Lee B, Segarra C, Kang S, Ju Y, et al. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep. Int J Nanomed. 2015;10(Spec Iss):241–50.
CAS
Google Scholar
Ono K, Noguchi-Shinohara M, Samuraki M, Matsumoto Y, Yanase D, et al. Blood-borne factors inhibit Alzheimer’s β-amyloid fibril formation in vitro. Exp Neurol. 2006;202(1):125–32.
Article
CAS
PubMed
Google Scholar
Jarrett JT, Lansbury Jr PT. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell. 1993;73(6):1055–8.
Article
CAS
PubMed
Google Scholar
Ghosh P, Kumar A, Datta B, Rangachari V. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer’s disease. BMC Bioinform. 2010;11 Suppl 6:S24.
Article
Google Scholar
Jeong JS, Ansaloni A, Mezzenga R, Lashuel HA, Dietler G. Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation. J Mol Biol. 2013;425(10):1765–81.
Article
CAS
PubMed
Google Scholar
Salvadores N, Shahnawaz M, Scarpini E, Tagliavini F, Soto C. Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer’s disease. Cell Rep. 2014;7(1):261–8.
Article
CAS
PubMed
Google Scholar
Roher AE, Esh CL, Kokjohn TA, Castaño EM, Van Vickle GD, Kalback WM, et al. Amyloid β peptides in human plasma and tissues and their significance for Alzheimer’s disease. Alzheimers Dement. 2009;5(1):18–29.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arai H, Lee VM, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ. Expression patterns of β-amyloid precursor protein (β-APP) in neural and nonneural human tissues from Alzheimer’s disease and control subjects. Ann Neurol. 1991;30(5):686–93.
Article
CAS
PubMed
Google Scholar
Clifford PM, Zarrabi S, Siu G, Kinsler KJ, Kosciuk MC, Venkataraman V, et al. Aβ peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons. Brain Res. 2007;1142:223–36.
Article
CAS
PubMed
Google Scholar
Cho SM, Kim HV, Lee S, Kim HY, Kim W, Kim TS, et al. Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model. Sci Rep. 2014;4:6777.
Article
CAS
PubMed
PubMed Central
Google Scholar